Literature DB >> 8607152

False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.

K R Sayre1, R Y Dodd, G Tegtmeier, L Layug, S S Alexander, M P Busch.   

Abstract

BACKGROUND: The manufacturers' criteria for a positive human immunodeficiency virus type 1 (HIV-1) Western blot (WB) test were recently revised to require reactivity to only two of the following bands: p24, gp41, and gp120/160. In a recent report, low-risk blood donors were identified in whom nonspecific reactivity to multiple env antigens in WB testing resulted in apparently false-positive WBs by these criteria. The present study was conducted to verify the existence of false-positive WBs among noninfected donors and to assess the extent of this problem. STUDY DESIGN AND METHODS: Four donors classified as WB-positive on the basis of env-only (3 cases) or p24/env-only (1 case) patterns were investigated. Index and/or follow-up specimens were tested by polymerase chain reaction (PCR), by overlapping recombinant env antigens and synthetic peptides in enzyme immunoassays, and by deglycosylated and denatured antigen WBs. WB records from American Red Cross blood centers were reviewed to determine the frequency of env-only and p24/env-only patterns, relative to all positive WBs, from 1988 through 1993.
RESULTS: The four index-case donors denied risk and had stable WB reactivity during follow-up. HIV PCR was negative in all. Env reactivity was restricted to nonglycosylated gp41 epitopes; no gp120-specific reactivity was detected. For three of the four donors, env reactivity was mapped to a 20-amino acid N-terminal epitope of gp41. The rate of detecting WBs with these false-positive patterns increased from 0.6 percent of all positive WBs from 1988 to 1990 (4/776) to 8 percent in 1991 and 1992 (52/683), and then it declined to 6 percent in 1992 and 1993 (47/783). Env-only patterns predominated in 1991 and 1992, whereas p24/env-only patterns were more frequent following implementation of combined anti-HIV-1/HIV type 2 enzyme immunoassays in 1992.
CONCLUSION: Low-risk blood donors can have false-positive results on WB tests. Increased detection of env-only and p24/env-only WBs appears related to the enhanced sensitivity of newer enzyme immunoassays to gp41 and p24 antibodies. Donors with these patterns should undergo follow-up testing to document the presence or absence of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607152     DOI: 10.1046/j.1537-2995.1996.36196190514.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  A Case of False-Positive HIV Test in a Patient With Newly Diagnosed Hodgkin Lymphoma and Literature Review.

Authors:  Sumera Bukhari; Ahmed Dirweesh; Afolarin Amodu; Muhammad Nadeem; Sara L Wallach
Journal:  Cureus       Date:  2020-10-10

2.  Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation.

Authors:  O Garkavenko; M C Croxson; M Irgang; A Karlas; J Denner; R B Elliott
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 3.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.

Authors:  Hiroyu Hatano; Eric L Delwart; Philip J Norris; Tzong-Hae Lee; Joan Dunn-Williams; Peter W Hunt; Rebecca Hoh; Susan L Stramer; Jeffrey M Linnen; Joseph M McCune; Jeffrey N Martin; Michael P Busch; Steven G Deeks
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

5.  Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.

Authors:  C Giachetti; J M Linnen; D P Kolk; J Dockter; K Gillotte-Taylor; M Park; M Ho-Sing-Loy; M K McCormick; L T Mimms; S H McDonough
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

6.  Curcumin attenuates endothelial cell fibrosis through inhibiting endothelial-interstitial transformation.

Authors:  Xiao Chen; Xuliang Chen; Xiangxiang Shi; Zhan Gao; Zhigang Guo
Journal:  Clin Exp Pharmacol Physiol       Date:  2020-03-23       Impact factor: 2.557

7.  Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.

Authors:  Xiaoyan Yin; Jingmiao Wang; Chunguang Shan; Qiaojing Jia; Yanrui Bian; Haizhong Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  LncRNA SENCR promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-1-3p.

Authors:  Ruirui Cheng; Guowei Zhang; Yong Bai; Furui Zhang; Guojun Zhang
Journal:  Cell Cycle       Date:  2021-07-05       Impact factor: 5.173

9.  The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm.

Authors:  Derryck B Klarkowski; Joseph M Wazome; Kamalini M Lokuge; Leslie Shanks; Clair F Mills; Daniel P O'Brien
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.